An update of epigenetic drugs for the treatment of cancers and brain diseases: a comprehensive review

Z Sahafnejad, S Ramazi, A Allahverdi - Genes, 2023 - mdpi.com
Epigenetics has long been recognized as a significant field in biology and is defined as the
investigation of any alteration in gene expression patterns that is not attributed to changes in …

Epigenetics in human disease and prospects for epigenetic therapy

G Egger, G Liang, A Aparicio, PA Jones - Nature, 2004 - nature.com
Epigenetic mechanisms, which involve DNA and histone modifications, result in the
heritable silencing of genes without a change in their coding sequence. The study of human …

[HTML][HTML] Tet2 restrains inflammatory gene expression in macrophages

AH Cull, B Snetsinger, R Buckstein, RA Wells… - Experimental …, 2017 - Elsevier
Tet methylcytosine dioxygenase 2 (TET2) is one of the earliest and most frequently mutated
genes in clonal hematopoiesis of indeterminate potential (CHIP) and myeloid cancers …

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

S Stein, MG Ott, S Schultze-Strasser, A Jauch… - Nature medicine, 2010 - nature.com
Gene-modified autologous hematopoietic stem cells (HSC) can provide ample clinical
benefits to subjects suffering from X-linked chronic granulomatous disease (X-CGD), a rare …

Multiple drug resistance mechanisms in cancer

BC Baguley - Molecular biotechnology, 2010 - Springer
Multiple drug resistance (multidrug resistance; MDR), a phenomenon whereby human
tumours that acquire resistance to one type of therapy are found to be resistant to several …

Lost in transcription: p21 repression, mechanisms, and consequences

AL Gartel, SK Radhakrishnan - Cancer research, 2005 - AACR
The cyclin-dependent kinase inhibitor p21WAF1/CIP1 is a major player in cell cycle control
and it is mainly regulated at the transcriptional level. Whereas induction of p21 …

Changes in DNA methylation patterns in subjects exposed to low-dose benzene

V Bollati, A Baccarelli, L Hou, M Bonzini, S Fustinoni… - Cancer research, 2007 - AACR
Aberrant DNA methylation patterns, including global hypomethylation, gene-specific
hypermethylation/hypomethylation, and loss of imprinting (LOI), are common in acute …

Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases

B Brueckner, R Garcia Boy, P Siedlecki, T Musch… - Cancer research, 2005 - AACR
DNA methylation regulates gene expression in normal and malignant cells. The possibility to
reactivate epigenetically silenced genes has generated considerable interest in the …

Clinical development of histone deacetylase inhibitors as anticancer agents

DC Drummond, CO Noble, DB Kirpotin… - Annu. Rev …, 2005 - annualreviews.org
▪ Abstract Acetylation is a key posttranslational modification of many proteins responsible for
regulating critical intracellular pathways. Although histones are the most thoroughly studied …

5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology …

K Ghoshal, J Datta, S Majumder, S Bai… - … and cellular biology, 2005 - Am Soc Microbiol
Azacytidine-and 5-aza-deoxycytidine (5-aza-CdR)-mediated reactivation of tumor
suppressor genes silenced by promoter methylation has provided an alternate approach in …